NEW YORK (GenomeWeb) – Sigma-Aldrich said in its Form 10-Q filed last week with the US Securities and Exchange Commission that it expects to eliminate about 80 jobs resulting from an upcoming facility consolidation in Europe. Employee termination costs are anticipated to be around $4 million, while potential asset disposal costs are estimated at up to $12 million. The company said that it expects closure activities to begin in the second half of 2014. Sigma-Aldrich had about 9,000 employees as of Dec. 31, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."